Weight Loss & GLP-1 Treatment Referrals
Weight loss and GLP-1 telehealth connects patients considering treatments like semaglutide and tirzepatide with a licensed medical evaluation from home, rather than requiring an in-person weight loss clinic visit for every step of the process. Miracle Leaf does not perform this evaluation itself. We refer interested patients to Heally, an independent telehealth platform whose own licensed providers review your health history and determine whether a treatment is appropriate for you before anything is prescribed. The GLP-1 medication class includes both branded products that carry a specific FDA weight management approval and options that a provider may prescribe off-label, so the approval basis differs by drug and by route of administration rather than applying to the whole drug class at once. Below you will find dedicated pages covering injectable semaglutide, an oral semaglutide option, injectable tirzepatide, metformin as an off-label adjunct, and how Heally structures pricing and multi-month options, so you can read the page that matches what you are actually considering before you follow a referral link to Heally.
Source: FDA-approved label, Wegovy (semaglutide) injection, NDA 215256, June 2021, on the chronic weight management indication referenced above.